STX-003: mRNA-based Cancer Therapy for Tumor-Specific Expression of IL-12 via Programmable Genetic Circuits
Time: 3:00 pm
day: Conference Day Two
Details:
• STX-003 is a systemically delivered immune oncology drug targeting solid tumors and metastatic disease
• Programmable sensors embedded in STX-003 allow for cell-selective expression
• Engineered control using these sensors improves STX-003 tolerability without compromising efficacy in pre-clinical animal models
